Economy/Home · Economy

[Featured Stocks] mRNA-Related Stocks Rally Across the Board... Hanmi Pharmaceutical Leads with 10% Surge, OliX and Samyang Biopharm Rise in Tandem

On the morning of the 5th, mRNA (messenger ribonucleic acid) related stocks are showing strength across the board. Hanmi Pharmaceutical is leading the rally with a surge of more than 10%, while related stocks such as OliX and Samyang Biopharm are also continuing their gains, drawing keen attention f

Oseong Kwon
Staff Reporter
4 min read
[Featured Stocks] mRNA-Related Stocks Rally Across the Board... Hanmi Pharmaceutical Leads with 10% Surge, OliX and Samyang Biopharm Rise in Tandem
CBC News

On the morning of the 5th, mRNA (messenger ribonucleic acid) related stocks are showing strength across the board. Hanmi Pharmaceutical is leading the rally with a surge of more than 10%, while related stocks such as OliX and Samyang Biopharm are also continuing their gains, drawing keen attention from investors.

As of 9:12 a.m. on the 5th, Hanmi Pharmaceutical is trading at 470,000 won, up 46,500 won (+10.98%) from the previous trading day. It is recording the highest gain among related stocks today with a double-digit rise.

OliX is trading at 92,900 won, up 7,400 won (+8.65%) from the previous session. Samyang Biopharm is also trading at 41,500 won, up 2,250 won (+5.73%), posting a gain in the 5% range.

Hanmi Science is also up 2,500 won (+5.10%) at 51,500 won. It is also noteworthy that both Hanmi Pharmaceutical and Hanmi Science are posting gains of more than 5%.

Other related stocks are also mostly rising in the 3-4% range. Inventage Lab is trading at 23,000 won, up 1,000 won (+4.55%), and iNtODEWORLD (AiJin) is trading at 1,765 won, up 73 won (+4.31%). Nibec is up 510 won (+3.84%) at 13,780 won, and ST Pharm is up 2,600 won (+3.58%) at 75,300 won.

Green Cross is trading at 143,000 won, up 4,400 won (+3.17%), while Pharmcell is up 150 won (+1.66%) at 9,190 won and Seorin Bio is up 70 won (+1.95%) at 3,655 won.

As of 9:12 a.m. today, all major mRNA-related stocks are trending upward, with buying flowing into the overall related theme group early in the session. In particular, Hanmi Pharmaceutical is standing out with a gain in the 10% range, while OliX, Samyang Biopharm, and Hanmi Science are also expanding their gains, drawing attention to how the market will unfold for the rest of the day.

However, as it is still early in the session, whether the current upward trend will continue through the latter half of the regular trading session, and how the gains of individual stocks will change, remain to be seen.

[※ This article is for reference only in making investment decisions, and the final responsibility for investments lies with the investor.]

Oseong Kwon
Staff Reporter

CBC Globe publishes verified stories with editorial review, source checks, and tenant-specific publication standards.